Circular RNA Drugs Market Set for Rapid Expansion with 16.8% CAGR Through 2032
The global circular RNA drugs market is emerging as an important segment of the biotechnology and pharmaceutical industries as researchers increasingly explore innovative RNA-based therapeutic technologies. Circular RNA (circRNA) molecules have a covalently closed-loop structure that provides greater molecular stability compared with conventional linear RNA. Their ability to support prolonged protein expression and regulate biological processes is creating new opportunities across oncology, rare genetic disorders, infectious diseases and regenerative medicine.
The growing interest in precision medicine and advanced genetic therapies is encouraging biotechnology companies and research institutions to invest in circular RNA drug development.
According to a report by IntelMarketResearch, the Global Circular RNA Drugs Market was valued at USD 205 million in 2024 and is projected to grow from USD 256 million in 2025 to USD 783 million by 2032, representing a 16.8% CAGR during 2025–2032. North America currently leads the market in research and innovation activities, while Europe and Asia-Pacific are developing as important regions for circular RNA research and therapeutic development.
Read the complete Circular RNA Drugs Market report:
https://www.intelmarketresearch.com/global-circular-rna-drugs-forecast-2025-2032-394-2674
Contact:
IntelMarketResearch
Phone: +91 9169164321
Email: help@intelmarketresearch.com
Website: www.intelmarketresearch.com
The global circular RNA drugs market is emerging as an important segment of the biotechnology and pharmaceutical industries as researchers increasingly explore innovative RNA-based therapeutic technologies. Circular RNA (circRNA) molecules have a covalently closed-loop structure that provides greater molecular stability compared with conventional linear RNA. Their ability to support prolonged protein expression and regulate biological processes is creating new opportunities across oncology, rare genetic disorders, infectious diseases and regenerative medicine.
The growing interest in precision medicine and advanced genetic therapies is encouraging biotechnology companies and research institutions to invest in circular RNA drug development.
According to a report by IntelMarketResearch, the Global Circular RNA Drugs Market was valued at USD 205 million in 2024 and is projected to grow from USD 256 million in 2025 to USD 783 million by 2032, representing a 16.8% CAGR during 2025–2032. North America currently leads the market in research and innovation activities, while Europe and Asia-Pacific are developing as important regions for circular RNA research and therapeutic development.
Read the complete Circular RNA Drugs Market report:
https://www.intelmarketresearch.com/global-circular-rna-drugs-forecast-2025-2032-394-2674
Contact:
IntelMarketResearch
Phone: +91 9169164321
Email: help@intelmarketresearch.com
Website: www.intelmarketresearch.com
39 Views